Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety

Blood
Chung-Wah SiuHung-Fat Tse

Abstract

Ventricular tachyarrhythmias may occur during intravenous arsenic trioxide (As2O3). This has not happened during oral As2O3. Sixteen patients were studied by electrocardiography and 24-hour Holter monitoring at baseline, during and after oral As2O3 (As2O3-ON, As2O3-OFF). QT and corrected QT (QTc) were significantly longer during As2O3-ON than in As2O3-OFF, but QT and QTc dispersions were comparable. The patients' 24-hour heart rates were higher during As2O3-ON than in As2O3-OFF. QTc intervals at each hour were longer during As2O3-ON than in As2O3-OFF. However, QTc prolongation of more than 30 milliseconds only occurred at one time point (2 hours) after oral As2O3, resulting in QTc of more than 500 milliseconds in 3 of 16 patients, all within 4 hours of oral As2O3. Although the standard deviation of normal RR interval was lower during As2O3-ON, ratios of low frequency to high frequency power for As2O3-ON and As2O3-OFF were comparable. No ventricular proarrhythmias were observed. These observations, due to the lower peak plasma arsenic reached during oral As2O3, may explain the relative cardiac safety of oral As2O3.

References

Jun 1, 1994·British Heart Journal·P D Higham, R W Campbell
Nov 5, 1998·The New England Journal of Medicine·S L SoignetR P Warrell
Nov 27, 2002·European Journal of Clinical Pharmacology·C R KumanaY L Kwong
Sep 27, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean T BarbeySteven L Soignet
Feb 12, 2004·British Journal of Haematology·Dilip UnnikrishnanPeter H Wiernik
Mar 5, 2004·The New England Journal of Medicine·Dan M Roden
Oct 27, 2004·Expert Opinion on Drug Safety·Yok-Lam Kwong
Jul 19, 2005·The Journal of Clinical Investigation·Benoit DroletDan M Roden
Oct 29, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·A John Camm

❮ Previous
Next ❯

Citations

Apr 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H GillY L Kwong
Jun 8, 2014·Best Practice & Research. Clinical Haematology·Harry J IlandJohn F Seymour
Aug 17, 2014·Environmental Toxicology and Pharmacology·Wen-Xiao XuJinglong Yan
Jan 17, 2013·Current Treatment Options in Oncology·Harry J Iland, John F Seymour
Feb 9, 2012·Expert Opinion on Therapeutic Targets·Yok-Lam Kwong
Oct 6, 2006·Expert Review of Anticancer Therapy·Robin L Jones, Michael S Ewer
May 9, 2008·Expert Opinion on Drug Safety·Nenad Sarapa, Margaret R Britto
Jul 16, 2008·Drug Development and Industrial Pharmacy·Zhiwen YangJinnian Peng
Jun 24, 2008·Expert Opinion on Pharmacotherapy·Mark R Litzow
Dec 29, 2015·Blood Reviews·Pallawi TorkaElizabeth A Griffiths
Mar 8, 2008·Clinical Lymphoma & Myeloma·Mikkael A Sekeres
Sep 19, 2015·The Lancet Oncology·Alan K BurnettUNKNOWN UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group
Sep 8, 2011·Pediatric Blood & Cancer·Wing Y AuYok-lam Kwong
Jul 21, 2009·Journal of Pharmacological and Toxicological Methods·Liang GuoHeather Guthrie
Jul 20, 2010·Microbes and Infection·Ylva MolinNils-Gunnar Ilbäck
Apr 18, 2015·Blood Cancer Journal·C C CoombsM S Tallman
Jun 21, 2012·Blood·Harry J IlandUNKNOWN Australasian Leukaemia and Lymphoma Group
Dec 17, 2011·Blood·Jessica K Altman, Martin S Tallman
Mar 12, 2013·European Journal of Pharmacology·Masafumi KumazakiAkio Fujimura
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amrita KrishnanStephen J Forman
Jun 8, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elihu H Estey, Fred Hutchinson
Jan 12, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xichuang ChenZhimin Du
Dec 9, 2017·Journal of the American Heart Association·Andreu Porta-SánchezPaaladinesh Thavendiranathan
Feb 27, 2008·Acta Pharmacologica Sinica·Wing-Yan Au, Yok-Lam Kwong
Feb 16, 2019·Cardiovascular Research·Eric J ChowBorah Hong
Apr 3, 2014·International Journal of Oncology·Sze-Kwan LamJames Chung-Man Ho
Nov 14, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Monika LyczkoAleksander Bilewicz
May 11, 2018·Leukemia·Sabine KayserUwe Platzbecker
Nov 2, 2019·Journal of Cardiovascular Translational Research·Mohammed Alomar, Michael G Fradley
Oct 3, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amer M Zeidan, Steven D Gore
Feb 27, 2021·Pediatric Hematology and Oncology·Michael AbeleMartin Ebinger
Jul 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H GillY L Kwong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.